US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Acuitas Small Cap Active ETF

27.09

+0.10600.39%

Volume:890

Turnover:24.15K

Market Cap:83.97M

PE:- -

High:27.15

Open:27.09

Low:27.09

Close:26.98

52wk High:29.62

52wk Low:23.01

Shares:3.10M

Float Shares:3.10M

Volume Ratio:0.56

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

AIMS APAC REIT Unitholders Clear Key Mandates at 17th AGM

AIMS APAC REIT Details Use of S$100 Million Equity Fund Raising

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AIMS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AIMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIMS\",,,,,undefined,":{"symbol":"AIMS","market":"US","secType":"STK","nameCN":"Acuitas Small Cap Active ETF","latestPrice":27.0872,"timestamp":1791576000000,"preClose":26.9812,"halted":0,"volume":890,"delay":0,"changeRate":0.0039286614383347695,"floatShares":3100000,"shares":3100000,"eps":0,"marketStatus":"Market Closed","change":0.106,"latestTime":"10-09 16:00:00 EDT","open":27.09,"high":27.15,"low":27.0872,"amount":24146,"amplitude":0.002328,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":26.9812,"sharesOutstanding":3100000,"nav":26.97,"aum":84281250,"bidAskSpread":0,"volumeRatio":0.559467},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIMS\",,,,,undefined,":{"symbol":"AIMS","floatShares":3100000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.559467,"shares":3100000,"dividePrice":0,"high":27.15,"amplitude":0.002328,"preClose":26.9812,"low":27.0872,"week52Low":23.01,"pbRate":"--","week52High":29.62,"institutionHeld":0,"latestPrice":27.0872,"eps":0,"divideRate":0,"volume":890,"delay":0,"ttmEps":0,"open":27.09,"prevYearClose":25.42,"prevWeekClose":27.4141,"prevMonthClose":27.0483,"prevQuarterClose":27.0483,"fiveDayClose":27.4141,"twentyDayClose":27.5968,"sixtyDayClose":28.5186},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AIMS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AIMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AIMS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AIMS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668973975","title":"New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973975","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973975?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:32","pubTimestamp":1789763520,"startTime":"0","endTime":"0","summary":"New data revealed that healthcare providers prioritize drowsiness risk, duration of available data demonstrating long-term response and drug-drug interaction profile when selecting a treatment for tar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/18/3364953/0/en/new-teva-study-identifies-the-attributes-that-healthcare-providers-prioritize-when-selecting-a-treatment-for-tardive-dyskinesia-in-older-patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMS","LU0128526141.USD","HCSG","BK4137","BK4585","XBI","BK4588","GSIB","BK4207","LABU","XLV","BK4581","LU0029874061.USD","AIMS","TD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421466","title":"U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421466","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421466?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:30","pubTimestamp":1787142600,"startTime":"0","endTime":"0","summary":"Ecopipam(EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designationNDA acceptance is supported by positive Phase 3 data, which were published in JAMA Neurolo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347619/0/en/u-s-fda-accepts-teva-s-new-drug-application-nda-and-grants-priority-review-for-ecopipam-a-first-in-class-investigational-therapy-for-pediatric-patients-with-tourette-syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMI","ECG","BK4585","AIMS","BK4588","BK4157","LU0566484027.USD","LABU","BK4129","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660344739","title":"AIMS APAC REIT Unitholders Clear Key Mandates at 17th AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2660344739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660344739?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:51","pubTimestamp":1787136678,"startTime":"0","endTime":"0","summary":"AIMS APAC REIT ( ($SG:O5RU) ) just unveiled an announcement. AIMS APAC REIT held its 17th annual general meeting in Singapore on 28 July 2026, wher...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aims-apac-reit-unitholders-clear-key-mandates-at-17th-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aims-apac-reit-unitholders-clear-key-mandates-at-17th-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDIV","RJMG","REIT","SG","BPRE","APAC","BK4195","AGM","DFRA","PSCF","BK4209","IQRA","RNTY","YLDW","AIMS","BK4229","STmain","IVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548119","title":"AIMS APAC REIT Details Use of S$100 Million Equity Fund Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548119?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:19","pubTimestamp":1785925140,"startTime":"0","endTime":"0","summary":"AIMS APAC REIT ( ($SG:O5RU) ) has shared an announcement. AIMS APAC REIT has detailed the deployment of the approximately S$100 million raised in i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aims-apac-reit-details-use-of-s100-million-equity-fund-raising?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aims-apac-reit-details-use-of-s100-million-equity-fund-raising?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APAC","BK4209","BPRE","AIMS","RNTY","SG","REIT","MDIV","RJMG","IQRA","YLDW","IVRA","DFRA","PSCF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AIMS\",params:#limit:6,delay:false,,,undefined,":[]}}